Clinical trial
Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects?
NCT04135274 is registered in ClinicalTrials.gov with Tepecik Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects?
- Lead sponsor
- Tepecik Training and Research Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2015
- Completion date
- December 30, 2018
- Enrollment
- 57 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
neural tube defects, newborn sepsis